Scolaris Content Display Scolaris Content Display

Non‐invasive positive airway pressure therapy for obesity hypoventilation syndrome in adults

Esta versión no es la más reciente

Referencias

Additional references

American Academy of Sleep Medicine 2014

American Academy of Sleep Medicine. International Classification of Sleep Disorders. Darien, IL: American Academy of Sleep Medicine, 2014.

Berg 2001

Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health‐care resources in obesity‐hypoventilation syndrome. Chest 2001;120(2):377‐83.

Berger 2009

Berger KI, Goldring RM, Rapoport DM. Obesity hypoventilation syndrome. Seminars in Respiratory and Critical Care Medicine. 2009/05/20 2009; Vol. 30, issue 3:253‐61. [1098‐9048: (Electronic)]

Bickelmann 1956

Bickelmann AG, Burwell CS, Robin ED, Whaley RD. Extreme obesity associated with alveolar hypoventilation; a Pickwickian syndrome. American Journal of Medicine 1956;21(5):811‐8.

Buchmueller 2015

Buchmueller TC, Johar M. Obesity and health expenditures: evidence from Australia. Economics and Human Biology 2015;17:42‐58.

Castro‐Anon 2015

Castro‐Anon O, Perez de Llano LA, De la Fuente Sanchez S, Golpe R, Mendez Marote L, Castro‐Castro J, et al. Obesity‐hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One. 2015/02/12 2015; Vol. 10, issue 2:e0117808. [1932‐6203: (Electronic)]

GRADEpro GDT [Computer program]

McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 5 October 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Howard 2017

Howard ME, Piper AJ, Stevens B, Holland AE, Yee BJ, Dabscheck E, et al. A randomised controlled trial of CPAP versus non‐invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax. 2016/11/18 2017; Vol. 72, issue 5:437‐44. [1468‐3296: (Electronic)]

Kessler 2001

Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity‐hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001;120(2):369‐76.

Laaban 2005

Laaban J P, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005;127(3):710‐5.

Lewin 2016

Lewin S, Hendry M, Chandler J, Oxman AD, Michie S, Shepperd S, et al. Guidance for using the iCAT_SR: Intervention Complexity Assessment Tool for Systematic Reviews, Version 1.0. Cochrane Methods; 2016. http://methods.cochrane.org/sites/default/files/public/uploads/icat_sr_additional_file_4_2016_12_27.pdf Accessed 17 September 2016.

Masa 2015

Masa JF, Corral J, Alonso ML, Ordax E, Troncoso MF, Gonzalez M, et al. Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study. American Journal of Respiratory and Critical Care Medicine. 2015/04/29 2015; Vol. 192, issue 1:86‐95. [1535‐4970: (Electronic)]

McEvoy 2016

McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. New England Journal of Medicine 2016;375(10):919‐31.

Moher 2009

Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]

Mokhlesi 2007

Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep and Breathing 2007;11(2):117‐24.

Moore 2017

Moore GF, Evans RE, Hawkins J, Littlecott HJ, Turley R. All interventions are complex, but some are more complex than others: using iCAT_SR to assess complexity [editorial]. Cochrane Database of Systematic Reviews 2017, Issue 7. [DOI: 10.1002/14651858.ED000122]

Nowbar 2004

Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, et al. Obesity‐associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. American Journal of Medicine2004; Vol. 116, issue 1:1‐7. [0002‐9343: (Print)]

Perez de Llano 2005

Perez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vazquez Caruncho M, Caballero Muinelos O, et al. Short‐term and long‐term effects of nasal intermittent positive pressure ventilation in patients with obesity‐hypoventilation syndrome. Chest 2005;128(2):587‐94.

Piper 2008

Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008/01/22 2008; Vol. 63, issue 5:395‐401. [1468‐3296: (Electronic)]

Priou 2010

Priou P, Hamel JF, Person C, Meslier N, Racineux JL, Urban T, et al. Long‐term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest 2010;138(1):84‐90.

Rapoport 1986

Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnoea syndrome: A reevaluation of the "Pickwickian Syndrome". Chest 1986;89(5):627‐35.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Senaratna 2017

Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Medicine Reviews. 2016/08/29 2017; Vol. 34:70‐81. [1532‐2955: (Electronic)]
Table 1. Assessment of intervention complexity using the iCAT_SR tool

Dimension

Assessment

Comments

1. Active components included in the intervention, in relation to the comparison

One component

The active component is the delivery of non‐invasive PAP therapy.

2. Behaviour or actions of intervention recipients or participants to which the intervention is directed

Single target

The intervention is directed at one behaviour, the nightly use of non‐invasive PAP therapy.

3. Organisational levels and categories targeted by the intervention

Single category

The intervention is directed at individual patients.

4. The degree of tailoring intended or flexibility permitted across sites or individuals in applying or implementing the intervention

Varies from inflexible to highly flexible

The intervention has potential to be tailored both in content (e.g. mask/interface) and form (e.g. pressure settings).

5. The level of skill required by those delivering the intervention in order to meet the intervention objectives

High level skills

Specialised clinical skills are required for prescription, setup and monitoring of the intervention.

6. The level of skill required for the targeted behaviour when entering the included studies by those receiving the intervention, in order to meet the intervention objectives

Intermediate level skills

Participants require education and training in order to apply the intervention at home.

7. The degree of interaction between intervention components, including the independence/interdependence of intervention components

Independent

The intervention has only one component.

8. The degree to which the effects of the intervention are dependent on the context or setting in which it is implemented

Varies from independent to highly dependent of context

This intervention is likely to be dependent on societal, economic and health system context.

9. The degree to which the effects of the intervention are changed by recipient or provider factors

Highly dependent on individual‐level factors

The intervention is likely to be dependent on the skills of the provider and the individual factors of the recipient.

10. The nature of the causal pathway between the intervention and the outcome it is intended to effect

Pathway variable, long

The causal pathway is complex and incompletely elucidated.

Figuras y tablas -
Table 1. Assessment of intervention complexity using the iCAT_SR tool